An inconsistent association between SSTR2 and AIP was clinically suggested from the finding that SSTR2 staining was not always reduced in pituitary somatotroph adenomas regardless of the presence or absence of Aip mutations [14]. This evidence concerns the gene SSTR2 and growth hormone-secreting pituitary adenoma.